Candice Limper

498 citations
11 papers · 341 · 1 hit paper · h-index 5

Impact in

    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
    • Immunotherapy and Immune Responses
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Immune Cell Function and Interaction 4
    • T-cell and B-cell Immunology 2
    • IL-33, ST2, and ILC Pathways 1
    • Air Quality and Health Impacts 3
    • Effects and risks of endocrine disrupting chemicals 1

Candice Limper

8 papers receiving 336 citations

Candice Limper's Hit Papers

Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy 2018 · 253 citations
2530+2+5Years since publication50100150200250

Peers

Candice Limper
Comparison fields: 5 of 61
  • Immunology 147
  • Oncology 137
  • Genetics 42
  • Pathology and Forensic Medicine 68
  • Radiology, Nuclear Medicine and Imaging 73
Replace Michael Fusco with:
Michael Fusco United States
Paige M. Bracci United States
Mikio Danbara Japan
Kyoko Kobuke Japan
Petra Martin Ireland
C. Sloane Furniss United States
Manfred Ahlgrimm Germany
Donald Gravenor United States
Mariko Sakata Japan
A McClure United Kingdom
Candice Limper relative to Michael Fusco United States Michael Fusco's profile →
Citations per field
00.5×10×16.5×
Michael Fusco · 1×
Citations per year

Countries citing papers authored by Candice Limper

Since Specialization
Citations

This map shows the geographic impact of Candice Limper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Candice Limper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Candice Limper more than expected).

Fields of papers citing papers by Candice Limper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Candice Limper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Candice Limper. The network helps show where Candice Limper may publish in the future.

Co-authors

The 18 scholars most cited alongside Candice Limper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Candice Limper Line = papers co-authored together Candice Limper links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy
Hit paper breakdown →
2018253
2 202045
3 202120
4 202011
5 20236
6 20212
7 20212
8 20202
9 20250
10 20230
11 20220

About Candice Limper

Candice Limper is a scholar working on Immunology, Health, Toxicology and Mutagenesis, Environmental Chemistry, Epidemiology and Surgery, having authored 11 papers that have together received 341 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (4 papers), Per- and polyfluoroalkyl substances research (3 papers), Air Quality and Health Impacts (3 papers), T-cell and B-cell Immunology (2 papers), Metabolism and Genetic Disorders (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Effects and risks of endocrine disrupting chemicals (1 paper) and IL-33, ST2, and ILC Pathways (1 paper). The work is most often cited by research in Immunology (147 citations), Oncology (137 citations), Genetics (42 citations), Pathology and Forensic Medicine (68 citations) and Radiology, Nuclear Medicine and Imaging (73 citations). Candice Limper has collaborated with scholars based in United States. Frequent co-authors include Timothy M. Pierpont, Kristy L. Richards, Avery August, Weishan Huang, Fei Huang, Luisa Torres, Teresa Southard, Kaixiong Ye, Lu Huang and Michael C. McGee. Their work appears in journals such as The Journal of Immunology, Frontiers in Immunology, Immunobiology, Frontiers in Veterinary Science and Frontiers in Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact